U.S. health regulators are investigating complaints about laboratory and research practices at Theranos Inc. by two former employees of the blood-testing startup company, according to people familiar with the inquiries. A complaint filed in September by a former Theranos lab employee to the Centers for Medicare and Medicaid Services alleged that management instructed lab employees to keep testing patients with the company’s blood-analysis devices despite indications of “major stability, precision and accuracy” problems with...
Citing people familiar with the topic , the Wall Street report reports that US health regulators are investigating further complaints against customers , specifically around the diagnostics company 's laboratory and research facilities . This move follows a series of investigatory actions by the US Government against the one - time darling of healthcare venture capital investment ; prior to October 's revelations Theranos was relatively high , having amassed over $ 9bn in venture capital funding to date , in its bid to revolutionise the diagnostics industry . New complaints indicate that customer tests continued despite reports that the devices performing them had “ major stability , precision and accuracy ” issues . While both the CMS and FDA declined to comment , Theranos said it had not seen the alleged complaint ; nevertheless , further enquiries by customers will likely tarnish the start - up 's already dented reputation .